These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9633007)

  • 1. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.
    Schrappe M; Lauterbach K
    AIDS; 1998; 12 Suppl A():S231-8. PubMed ID: 9633007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on cost effectiveness of HIV prevention interventions in the United States.
    Huang YL; Lasry A; Hutchinson AB; Sansom SL
    Appl Health Econ Health Policy; 2015 Apr; 13(2):149-56. PubMed ID: 25536927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
    Karnon J; Orji N
    Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.
    Johnson-Masotti AP; Weinhardt LS; Pinkerton SD; Otto-Salaj LL
    J Ment Health Policy Econ; 2003 Mar; 6(1):23-35. PubMed ID: 14578545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons.
    Holtgrave DR
    AIDS; 2005 Nov; 19(17):2025-9. PubMed ID: 16260910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations.
    Bloch SCM; Jackson LJ; Frew E; Ross JDC
    Sex Transm Infect; 2021 Aug; 97(5):334-344. PubMed ID: 33653881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A social cost-benefit criterion for evaluating Voluntary Counseling and Testing with an application to Tanzania.
    Brent RJ
    Health Econ; 2010 Feb; 19(2):154-72. PubMed ID: 19266590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and quality assessment of economic evaluation studies of injury prevention.
    Polinder S; Segui-Gomez M; Toet H; Belt E; Sethi D; Racioppi F; van Beeck EF
    Accid Anal Prev; 2012 Mar; 45():211-21. PubMed ID: 22269503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.